Neogen Corporation (NEOG) - Cash Flow Conversion Efficiency

Latest as of May 2026: 0.014x

Based on the latest financial reports, Neogen Corporation (NEOG) has a cash flow conversion efficiency ratio of 0.014x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($30.20 Million) by net assets ($2.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NEOG company net worth for the company's overall valuation and market capitalisation.

Neogen Corporation - Cash Flow Conversion Efficiency Trend (1992–2026)

This chart illustrates how Neogen Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Neogen Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neogen Corporation ranked by their cash flow conversion efficiency. Explore Neogen Corporation (NEOG) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Shurgard Self Storage SA
BR:SHUR
0.020x
Talos Energy
NYSE:TALO
0.148x
Cohu Inc
NASDAQ:COHU
0.013x
China Baoan Group Co Ltd
SHE:000009
0.010x
Dongyue Group Limited
F:4D3
0.018x
Infleqtion, Inc.
NYSE:INFQ
-0.033x
Comet Holding AG
SW:COTN
0.119x
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
0.053x

Annual Cash Flow Conversion Efficiency for Neogen Corporation (1992–2026)

The table below shows the annual cash flow conversion efficiency of Neogen Corporation from 1992 to 2026. View NEOG stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-05-31 $2.09 Billion $83.20 Million 0.040x +41.37%
2025-05-31 $2.07 Billion $58.24 Million 0.028x +150.72%
2024-05-31 $3.14 Billion $35.26 Million 0.011x -14.32%
2023-05-31 $3.13 Billion $41.03 Million 0.013x -82.93%
2022-05-31 $887.37 Million $68.04 Million 0.077x -20.54%
2021-05-31 $840.38 Million $81.09 Million 0.096x -18.52%
2020-05-31 $725.18 Million $85.88 Million 0.118x +18.33%
2019-05-31 $637.90 Million $63.84 Million 0.100x -18.90%
2018-05-31 $560.17 Million $69.13 Million 0.123x -3.41%
2017-05-31 $471.76 Million $60.27 Million 0.128x +46.15%
2016-05-31 $404.16 Million $35.33 Million 0.087x -29.94%
2015-05-31 $350.96 Million $43.79 Million 0.125x +76.38%
2014-05-31 $306.30 Million $21.67 Million 0.071x -31.21%
2013-05-31 $258.29 Million $26.56 Million 0.103x +1.12%
2012-05-31 $219.05 Million $22.28 Million 0.102x -33.37%
2011-05-31 $188.98 Million $28.84 Million 0.153x -16.54%
2010-05-31 $153.05 Million $27.99 Million 0.183x +114.21%
2009-05-31 $128.68 Million $10.98 Million 0.085x +20.63%
2008-05-31 $111.25 Million $7.87 Million 0.071x -35.94%
2007-05-31 $91.94 Million $10.16 Million 0.110x -42.08%
2006-05-31 $64.55 Million $12.31 Million 0.191x +55.61%
2005-05-31 $54.84 Million $6.72 Million 0.123x +96.74%
2004-05-31 $47.84 Million $2.98 Million 0.062x -61.50%
2003-05-31 $41.40 Million $6.70 Million 0.162x +69.41%
2002-05-31 $35.55 Million $3.40 Million 0.096x +12.29%
2001-05-31 $29.34 Million $2.50 Million 0.085x -53.05%
2000-05-31 $25.80 Million $4.68 Million 0.181x +16.56%
1999-05-31 $23.80 Million $3.70 Million 0.155x +144.59%
1998-05-31 $23.60 Million $1.50 Million 0.064x -41.97%
1997-05-31 $21.00 Million $2.30 Million 0.110x +8.31%
1996-05-31 $8.90 Million $900.00K 0.101x +277.98%
1995-05-31 $8.80 Million $-500.00K -0.057x -125.74%
1994-05-31 $7.70 Million $1.70 Million 0.221x +436.69%
1993-05-31 $6.10 Million $-400.00K -0.066x +40.05%
1992-05-31 $6.40 Million $-700.00K -0.109x --

About Neogen Corporation

NASDAQ:NEOG USA Medical Devices
Market Cap
$2.80 Billion
Market Cap Rank
#5341 Global
#1774 in USA
Share Price
$12.83
Change (1 day)
+2.23%
52-Week Range
$5.36 - $12.83
All Time High
$48.34
About

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage … Read more